- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03533738
Effects of Food Sequence on the Glycaemic and Insulinaemic Responses
July 16, 2020 updated by: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The study hypothesizes that vegetable and protein consumed before a carbohydrate will reduce the glucose response.
The vegetables and protein consumed before carbohydrate have different effects on insulin and satiety responses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Up to 20 healthy subjects will be recruited for the study and before inclusion in the study, potential participants will be given the opportunity to ask questions.
Subjects who will fulfill all the acceptable criteria(Chinese ethnicity, body mass index between 18-25 kg/m2, weight of at least 45kg, normal blood pressure,less than or equal 140 and 90 mmHg; age between 21-40 years, fasting blood glucose less than 6 mmol/L) may be included in the study.Each subject will be asked to complete a screening session(lasting approximately1 hour) in a fasted state where baseline measurements including anthropometric measurements, fasting blood glucose and blood pressure will be collected from each participant to assess their eligibility.On the day before each test, enrolled subjects will be asked to restrict their intake of alcohol and caffeine-containing drinks and to restrict their participation in intense physical activity (eg, long periods at the gym, intensive swimming, running, aerobics etc).
There is a total of five test sessions.
Test sessions will be interspaced by a minimum of 1 week.
For each session, subjects are required to come between 8:00-9:00am, with each session lasting approximately 4 hours.
Subjects would have to come following a 10-12 hour overnight fast.
An indwelling catheter will be inserted into a vein in your forearm and will be kept patent (free of clots) for the remainder of the test session.
The investigators will then take a blood sample from the cannula to measure baseline values.
The investigators will also take a finger prick blood sample to measure blood glucose concentration.
After obtaining the baseline blood samples the investigators will give subjects the test meal in different sequence consume in 15 minutes.
Following the meal we will take further blood samples (from the cannula and finger pricks) for the next 15, 30, 45, 60, 90, 120, 150 and180 minutes.
The amount of blood that will be collected at every time point will be about1.2
teaspoon of blood (approximately 6 mL).At the same time intervals the subjects will be instructed to fill in visual analogue scales on feelings of fullness, hunger, desire to eat and prospective food consumption.Visual analogue scales are 100 mm continuous lines anchored with opposing answers to a specific question asked.
The specific questions asked will be, 'How hungry do you feel?', 'How full do you feel?', 'How strong is your desire to eat?', ' How much more food do you think you can eat?'.
The subjects will be instructed to make a mark on the line which corresponds with their subjective feeling.
After 3 hours, the cannula will be removed and the subjects will be instructed to an ad libitum lunch.
After finish the lunch, the subjects will also be asked to complete a visual analogue scales (VAS) for the measurement of hunger and feelings of fullness.
After which,subjects are free to leave Clinical Nutrition Research Centre.
During the entire testing period the subjects will be instructed to remain rested and in the laboratory.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chinese ethnicity
- Age between 21-40 years
- Weight of at least 45 kg
- Body mass index between 18 to 25 kg/m2
- Normal blood pressure (≤140/90 mmHg)
- Fasting blood glucose <6.0 mmol/L
Exclusion Criteria:
- Are a female who is pregnant
- Partake in sports at the competitive and/or endurance levels
- Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Have major chronic disease such as heart disease, cancer or diabetes mellitus
- Take insulin or drugs known to affect glucose metabolism
- Intentionally restrict food intake
- Have major medical or surgical event requiring hospitalization within the preceding 3 months
- Have taken antibiotics for 3 months before the study period
- Are a smoker
- Are an overnight shift worker
- Have any known food allergy (example anaphylaxis to peanuts)
- Having active Tuberculosis (TB) or currently receiving treatment for TB
- Have any known Chronic Infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV).
- Are a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
- Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC
- Have poor veins impeding venous access
- Have any history of severe vasovagal syncope blackouts or near faints following blood draws
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Food selection 1
To consume vegetables followed by meat & rice together
|
Vegetables first then meat & rice together
|
Experimental: Food selection 2
To consume meat followed by vegetables & rice together
|
Meat first then vegetables & rice together
|
Experimental: Food selection 3
To consume as follows: vegetables, meat, rice
|
Vegetables first then meat followed by rice
|
Experimental: Food selection 4
To consume vegetables followed by meat and rice together
|
Vegetables first followed by meat and rice together
|
Experimental: Food selection 5
To consume rice followed by vegetables & meat together
|
Rice first followed by vegetables & meat together
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
glycemic response
Time Frame: up to 180 minutes
|
using Hemocue analyzer
|
up to 180 minutes
|
Insulin response
Time Frame: up to 180 minutes
|
using COBAS Analyzer
|
up to 180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 12, 2017
Primary Completion (Actual)
March 17, 2020
Study Completion (Actual)
March 17, 2020
Study Registration Dates
First Submitted
May 11, 2018
First Submitted That Met QC Criteria
May 11, 2018
First Posted (Actual)
May 23, 2018
Study Record Updates
Last Update Posted (Actual)
July 17, 2020
Last Update Submitted That Met QC Criteria
July 16, 2020
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2017/00742
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Food sequence 1
-
University of Colorado, DenverJohnson & JohnsonCompleted
-
Centre Hospitalier Universitaire DijonRecruiting
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Yuhan CorporationCompletedHealthyKorea, Republic of
-
University of CopenhagenNordea-fondenCompletedGlucose Intolerance | Insulin SensitivityDenmark
-
Samyang Biopharmaceuticals CorporationCompletedHyperlipidemiaKorea, Republic of
-
Synthetic Biologics Inc.CompletedHealthy VolunteersCanada, United States
-
Janssen Research & Development, LLCCompletedEjaculationUnited States
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedHealthy VolunteersUnited States